Autoinjectors are the medical devices that are essentially used by the diabetic patients to inject insulin inn their bodies instead of the hesitation caused by the needle given by doctor in their clinics. With the help of autoinjectors, the patient is ultimately motivated to ignore and get rid of the needles and subsequent medication flow solely via the pressure application on the injection area. The pressure leads to actuation of needle shield that allows the needle to get engaged and cause the device to inject the required drug. On the other hand, the pen injectors serve patients with different chronic diseases. These patients need regular medication doses to reduce of stabilize their symptoms.
Autoinjectors market is anticipated to grow at a CAGR of 19.0% from 2019 to 2030.
The global autoinjectors market is driven by growing popularity of targeted therapies and increasing number of regulatory approvals. Moreover increasing incidences of anaphylaxis, availability of generic versions of autoinjectors and growing geriatric population is anticipated to further contribute to the growing demand of the global autoinjectors market during the forecast period. However, availability of conventional drug delivery systems like syringes s likely to restrain the market to a certain extent.
Major Key Players of the Autoinjectors Market are:
Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.
No comments:
Post a Comment